Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Aim To analyse changes in haematological values after plateletpheresis in donor population with regard to donor safety. Methods A retrospective study was conducted on first time and repeated healthy donors over a period of eight months in the Blood Transfusion Institute in the Federation of Bosnia and Herzegovina in Sarajevo. A total of 75 plateletpheresis procedures performed using Amicus continuous flow cell separator were evaluated. Various pre- and post-donation haematological values were measured in all donors: haemoglobin concentration (Hb), haematocrit (Hct), red blood cell count (RBC), platelet count (PLT), white blood cell count (WBC), mean platelet volume (MPV), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean corpuscular haemoglobin concentration (MCHC). Results A significant decrease in post-donation Hb, Hct, RBC, PLT, MCHC (p<0.000) and WBC (p=0.003), and a significant increase in MPV (p=0.011) and MCV (p<0.000) was found. Percentage reduction of haematological parameters Hb, Hct, RBC, PLT, WBC and MCHC decrease of 6.6%, 6.5%, 5.9%, 24%, 4.6% and 0.3%, respectively, in their respective count was noted postdonation. Eight (11%) donors had a post-procedure platelet count less than 150x10e9/L. Twenty two donors (29%) experienced mild side effects due to hypocalcaemia. Conclusion Plateletpheresis procedures are generally safe and well tolerated, without evident associated clinical manifestations on healthy donors.
Lewis SM, Anderson NA, Pamphilon DH. Comparability of haematological and biochemical parameters before and after apheresis of volunteer donors. Vox Sang 1991;61;(78).
2
Blood Transfusion EC. Guide to the Preparation, Use and Quality Assurance of Blood Components; Recommendation No.R(95)15; 21st Edition. European Directorate for the Quality of Medicines & Health Care Council of Europe 2023:254–6.
3
Dogra K, Fulzele P, Rout D, Chaurasia R, Coshic P, Chatterjee K. Adverse events during apheresis procedures: audit at a tertiary hospital. Indian J Hematol Blood Transfus 2017;33:106–8.
4
Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher 2012;27:117–25.
5
Chaundhary R, Das SS, Khetan D, Sinha P. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator. Transfus Apher Sci 2006;34:157–61.
6
Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006;107:1747–50.
7
Nomani L, Raina TR, Sidhu M. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective. Transfus Apher Sci 2013;48:341–3.
8
Setiadarma D, Angela. Effects of plateletpheresis on hematological parameters. World J Curr Med Pharm Res 2022;4:122–6.
9
Lazarus EF, Browning J, Norman J, Oblitas J, Leitman SF. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 2001;41:756–61.
10
Lowe E, Pendry K, Hunt L. Analysis of pre- and post-donation haematological values in plateletpheresis donors. Vox Sang 1993;65:209–11.
11
Aslam MU, Alam M, Zafar MU, Akhter M, Awais H, Mannan T, et al. Preliminary study of variation in pre and post hematological values of healthy plateletpheresis donors. Int J Endorsing Health Sci Res 2021;9:360–4.
12
Suresh B, Arun R, Yashovardhan A, Deepthi K, Sreedhar Babu KV, Jothibai DS. Changes in preand post-donation haematological parameters in plateletpheresis donors. J Clin Sci Res 2014;3:85–9.
13
Beyan C, Cetin T, Kaptan K, Nevruz O. Effect of plateletpheresis on complete blood count values using different cell separator systems in healthy donors. Transfus Apher Sci 2003;29:45–7.
14
Nikhil DS, Snigdha. Haematological changes in donors post apheresis. J Clin Diagn Res 2021;15:39–41.
15
Gite V, Dhakane M. Analysis of pre- and post-donation haematological values in plateletpheresis donors. Apollo Medicine 2015;12:123–5.
16
Farahat MH, Sharaf MA. Hematological and biochemical parameter alteration after plateletpheresis donation. Egypt J Haematol 2016;41:174–9.
17
AK SN, M NA, AT NS, M N, E A, A NA, et al. Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia. Transfus Apher Sci 2013;49:507–10.
18
Khajuria K, Sawhney V, Sharma R, Gupta S. Adverse donor reaction during and after plateletpheresis in a tertiary care centre. Int J Res Med Sci 2017;5:1221–3.
19
Chaudhary R, Das SS, Khetan D, Ojha S, Verma S. Donor safety issues in high-dose platelet collection using the latest apheresis systems. Transfus Altern Transfus Med 2010;11:1–7.
20
Sachdeva P, Kaur G, Basu S, Tahlan A. Assessment of factors affecting the platelet yield using continuous flow cell separator. Int J Biomed Res 2014;5:196–9.
21
Das SS, Chaudhary R, Verma SK, Ojha S, Khetan D. Pre- and post donation haematological values in healthy donors undergoing plateletpheresis with five different systems. Blood Transfus 2009;7:188–92.
22
Mahmood W, Rifin N, Iberahim S, Long Tuan M, Mustafa R. Significant reduction in hematological values after plateletpheresis: clinical implication to the donor. Asian Biomed 2011;5:393–5.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
